Literature DB >> 33734290

Finding the Optimal Thromboprophylaxis Dose in Patients With COVID-19.

Hanny Al-Samkari1,2.   

Abstract

Entities:  

Year:  2021        PMID： 33734290     DOI： 10.1001/jama.2021.4295

Source DB:  PubMed          Journal:  JAMA        ISSN： 0098-7484            Impact factor:   56.272


× No keyword cloud information.
  7 in total

1.  Thromboprophylaxis in people hospitalized with COVID-19: Assessing intermediate or standard doses in a retrospective cohort study.

Authors:  Kathleen M Andersen; Corey S Joseph; Hemalkumar B Mehta; Michael B Streiff; Joshua F Betz; Robert C Bollinger; Arielle M Fisher; Amita Gupta; Charles F LeMaistre; Matthew L Robinson; Yanxun Xu; Derek K Ng; G Caleb Alexander; Brian T Garibaldi
Journal:  Res Pract Thromb Haemost       Date:  2022-07-15

Review 2.  Anticoagulants for people hospitalised with COVID-19.

Authors:  Ronald Lg Flumignan; Vinicius T Civile; Jéssica Dantas de Sá Tinôco; Patricia If Pascoal; Libnah L Areias; Charbel F Matar; Britta Tendal; Virginia Fm Trevisani; Álvaro N Atallah; Luis Cu Nakano
Journal:  Cochrane Database Syst Rev       Date:  2022-03-04

3.  Anti-viral treatment for SARS-CoV-2 infection: A race against time amidst the ongoing pandemic.

Authors:  Natalia G Vallianou; Dimitrios Tsilingiris; Gerasimos Socrates Christodoulatos; Ιrene Karampela; Maria Dalamaga
Journal:  Metabol Open       Date:  2021-05-25

4.  COVID-19 is associated with higher risk of venous thrombosis, but not arterial thrombosis, compared with influenza: Insights from a large US cohort.

Authors:  Andrew Ward; Ashish Sarraju; Donghyun Lee; Kanchan Bhasin; Sanchit Gad; Rob Beetel; Stella Chang; Mac Bonafede; Fatima Rodriguez; Rajesh Dash
Journal:  PLoS One       Date:  2022-01-12       Impact factor: 3.240

Review 5.  Comprehensive Review of Cardiovascular Complications of Coronavirus Disease 2019 and Beneficial Treatments.

Authors:  Francine K Welty; Nazanin Rajai; Maral Amangurbanova
Journal:  Cardiol Rev       Date:  2022 May-Jun 01       Impact factor: 2.644

6.  Thromboembolic events in COVID-19 ambulatory patients: An observational study about incidence, and thromboprophylaxis outcomes.

Authors:  Rania Hammami; Jihen Jdidi; Olfa Chakroun; Fadhila Issaoui; Nouha Ktata; Hanen Maamri; Mouna Baklouti; Amine Bahloul; Rania Gargouri; Abdennour Nasri; Sameh Msaad; Samy Kammoun; Samir Kammoun; Imen Ben Rejab; Selma Charfeddine; Leila Abid
Journal:  PLoS One       Date:  2022-08-04       Impact factor: 3.752

Review 7.  Therapeutic advances in COVID-19.

Authors:  Naoka Murakami; Robert Hayden; Thomas Hills; Hanny Al-Samkari; Jonathan Casey; Lorenzo Del Sorbo; Patrick R Lawler; Meghan E Sise; David E Leaf
Journal:  Nat Rev Nephrol       Date:  2022-10-17       Impact factor: 42.439
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.